Tailoring Adjuvant Radiotherapy in Endometrial Cancer

Narayan, Kailash; Lin, Ming Yin; Bernshaw, David; Khaw, Pearly; Kondalsamy-Chennakesvan, Srinivas

doi:10.1007/s40944-017-0136-y

Cited by 1 publication

(2 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Isolated para‐aortic recurrences, although infrequent, are salvageable. Twenty‐two of the 29 such recurrences could be salvaged, resulting in median survival of 3.5 (1–15) years …”

Section: Imaging and Treatment Of Recurrent Endometrial Cancermentioning

confidence: 99%

See 1 more Smart Citation

Role of imaging in the routine management of endometrial cancer

Lin

Dobrotwir

McNally

et al. 2018

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

Endometrial cancer is the most common gynecologic cancer in women today. It is surgically staged, and while surgery is the primary treatment modality, the identification of disease extent—in particular extrauterine spread—prior to surgery is important to optimize treatment decision making. Ultrasound and MRI are useful for evaluating the extent of local disease, while CT and PET are used for detecting lymph node or distant metastases. Diffusion-weighted MRI has also been used for detecting small metastatic deposits in lymph nodes and omentum. Extrauterine soft tissue involvement can be detected by ultrasound, CT, MRI, and PET. Recently, intraoperative visualization techniques, such as sentinel lymph node mapping, are increasingly used to avoid extensive surgical staging without compromising treatment. Imaging is also used for planning adjuvant treatment and detection of postoperative residual disease in high-risk patients, monitoring and detecting recurrent disease, and in post-treatment surveillance of asymptomatic patients with high risk of relapse.

show abstract

“…Isolated para‐aortic recurrences, although infrequent, are salvageable. Twenty‐two of the 29 such recurrences could be salvaged, resulting in median survival of 3.5 (1–15) years …”

Section: Imaging and Treatment Of Recurrent Endometrial Cancermentioning

confidence: 99%

“…Twenty-two of the 29 such recurrences could be salvaged, resulting in median survival of 3.5 (1-15) years. 40…”

mentioning

confidence: 99%